Robert G. Savage's Net Worth
$1.35 Million
Who is Robert G. Savage?
Robert G. Savage has an estimated net worth of $1.35 Million. This is based on reported shares across multiple companies, which include SAVIENT PHARMACEUTICALS INC, HUMANIGEN, INC, MedWorth Acquisition Corp., NOVADEL PHARMA INC, DEPOMED INC, EPICEPT CORP, PANACOS PHARMACEUTICALS, INC., NOVEN PHARMACEUTICALS INC, and MEDICINES CO /DE.
SEC CIK
Robert G. Savage's CIK is 0001232506
Past Insider Trading and Trends
2007 was Robert G. Savage's most active year for acquiring shares with 18 total transactions. Robert G. Savage's most active month to acquire stocks was the month of April. 2013 was Robert G. Savage's most active year for disposing of shares, totalling 9 transactions. Robert G. Savage's most active month to dispose stocks was the month of July. 2005 saw Robert G. Savage paying a total of $608,000.00 for 522,500 shares, this is the most they've acquired in one year. In 2015 Robert G. Savage cashed out on 47,500 shares for a total of $815,711.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SAVIENT PHARMACEUTICALS INC No price found
InvestorRobert G. Savage owns 16,149 units of Common Stock, $0.01 par value. In the year 2012 Robert G. Savage filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 16.15K |
$1.14 | $18,409.86 | 16.15K |
Dec 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HUMANIGEN, INC (HGEN) Snapshot price: $0.011
InvestorRobert G. Savage owns 199,869 units of Common Stock, $0.001 par value which is worth $2,198.56. In the year 2018 Robert G. Savage filed a total of 9 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
| +100.13% | 100K |
$0.67 | $66,500.00 | 199.87K |
May 14
| |||
Form 4
| +15.90% | 13.7K |
$1.35 | $18,500.40 | 99.87K |
Mar 29
| |||
Form 4
| +32.12% | 20.95K |
$0.74 | $15,500.04 | 86.17K |
Jan 3
| |||
Form 4
| +59.07% | 24.22K |
$0.64 | $15,500.16 | 65.22K |
Sep 28
| |||
Form 4
| +310.00% | 31K |
$0.50 | $15,500.00 | 41K |
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MedWorth Acquisition Corp. No price found
InvestorRobert G. Savage owns 34,375 units of Common Stock. In the year 2013 Robert G. Savage filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.00% | 3.13K |
—
|
—
| 34.38K |
Jun 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NOVADEL PHARMA INC No price found
Chairman the Board
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DEPOMED INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||